Sex-Specific Risk Factors for Short- and Long-Term Outcomes after Surgery in Patients with Infective Endocarditis.
gender
infective endocarditis
risk factors
sex-specific
survival
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Mar 2022
28 Mar 2022
Historique:
received:
14
02
2022
revised:
21
03
2022
accepted:
24
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
(1) Background: Surgery for infective endocarditis (IE) is associated with considerable mortality and it is controversial whether the female gender is predictive for a worse outcome. This large single-center study investigated the impact of sex on outcomes after surgery for IE. (2) Methods: 413 patients (25.4% female) were included into this retrospective observational study. Univariate and multivariable analyses identified sex-specific risk factors for 30 day and late mortality. Survival was estimated by the Kaplan-Meier-method. (3) Results: Women presented more often with mitral valve infection (p = 0.039). Men presented more frequently with previous endocarditis (p = 0.045), coronary heart disease (p = 0.033), and aortic valve infection (p = 0.005). Blood transfusion occurred more frequently intraoperatively in women (p < 0.001), but postoperatively in men (p = 0.015) and men had a longer postoperative stay (p = 0.046). Women showed a higher 30 day mortality than men (p = 0.007) and female gender was predictive for 30 day mortality (OR 2.090). Late survival showed no sex-specific difference (p = 0.853), and the female gender was not an independent predictor for late mortality (p = 0.718). Risk factors for early and late mortality showed distinct sex-specific differences such as increased preoperative CRP level in women and culture-negative IE in men.
Identifiants
pubmed: 35407487
pii: jcm11071875
doi: 10.3390/jcm11071875
pmc: PMC8999412
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Card Anaesth. 2017 Jan-Mar;20(1):76-82
pubmed: 28074801
Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):141-147
pubmed: 28927175
Scand J Infect Dis. 2007;39(2):101-7
pubmed: 17366025
PLoS One. 2013 Dec 09;8(12):e82665
pubmed: 24349331
Infection. 2019 Dec;47(6):879-895
pubmed: 31254171
Ann Thorac Surg. 2019 Apr;107(4):1111-1117
pubmed: 30476475
Eur J Cardiovasc Nurs. 2011 Dec;10(4):197-204
pubmed: 20870463
Eur Heart J. 2018 Feb 14;39(7):586-595
pubmed: 29161405
Heart. 2021 Nov;107(21):1717-1724
pubmed: 34290038
J Cardiothorac Surg. 2020 Jun 18;15(1):145
pubmed: 32552706
Front Cardiovasc Med. 2021 Nov 23;8:751421
pubmed: 34888363
BMJ Open. 2019 Apr 20;9(4):e026811
pubmed: 31005935
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Med Sci Monit. 2016 Jul 18;22:2520-7
pubmed: 27427831
Clin Med (Lond). 2020 Jan;20(1):31-35
pubmed: 31941729
J Clin Med. 2021 Apr 26;10(9):
pubmed: 33925866
Open Med (Wars). 2020 Jun 20;15(1):571-579
pubmed: 33336013
Anaesthesia. 2018 May;73(5):572-578
pubmed: 29349775
Cardiovasc Diagn Ther. 2017 Feb;7(1):27-35
pubmed: 28164010
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):336-45
pubmed: 26678152
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
BMC Cardiovasc Disord. 2021 Mar 16;21(1):138
pubmed: 33726669
Egypt Heart J. 2020 Jan 21;72(1):5
pubmed: 31965410
Am J Med Sci. 2021 Jan;361(1):83-89
pubmed: 32988595
PLoS One. 2017 Aug 30;12(8):e0184038
pubmed: 28854266
Eur Heart J. 2003 May;24(9):881-2
pubmed: 12727160
Heart. 2014 Aug;100(15):1173-8
pubmed: 24914062
Curr Cardiol Rep. 2018 Aug 16;20(10):86
pubmed: 30117004
Rev Esp Cardiol. 2008 Jan;61(1):36-40
pubmed: 18221689
Indian Heart J. 2018 Dec;70 Suppl 3:S43-S49
pubmed: 30595302
Am J Cardiol. 2010 Jul 1;106(1):92-8
pubmed: 20609654